KAKarolina Akinosoglou

Karolina Akinosoglou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karolina Akinosoglou has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Native valve right sided infective endocarditis

    by Karolina Akinosoglou, Efstratios Apostolakis, Markos Marangos, Geoffrey Pasvol


    • 1 January 2013
      • Vol. 17  (1) , 8-18

    Infectious complications in patients with lung cancer.

    by K S Akinosoglou, K Karkoulias, M Marangos

    Infections remain a part of the natural course of cancer. During the course of their disease, patients with lung cancer frequently present with an infection that can ultimately be fatal. Pathogenesis of infectious syndromes is usually determined by the underlying disease, as well as, the iatrogenic manipulations that occur during its management. Hence, lung cancer infections include lower respiratory tract infections in the context of COPD, aspiration, obstruction and opportunistic infections due to immunosuppression. Moreover, treatment-related infectious syndromes including post operative pneumonia, febrile neutropenia and superimposed infection following radiation/chemotherapy toxicity is common. Importantly, diagnosis of infection in the febrile lung cancer patient is challenging and requires a high index of suspicion in order to distinguish from other causes of fever, including malignant disease and pulmonary embolism. Prompt initiation of treatment is pivotal to avoid increased mortality. Careful consideration of infection pathogenesis can predict most likely pathogens and guide antibiotic management, thus, ensuring most favourable outcome.


  • Open Access

    Reply to Myers et al.

    by Karolina Akinosoglou, Efstratios Apostolakis

    The authors agree with Myers et al. [1] that biodegradable materials represent a useful alternative in the management of tricuspid valve endocarditis repair. Our statement of dividing tricuspid valve repair choices in prosthetic and non-prosthetic techniques adequately sets the main cornerstones of surgical therapy: first, minimizing, as much as possible, the resulting valve regurgitation following repair and second, equally avoiding the use of any prosthetic material [2]. This is particularly important for injecting drug users who bear a high possibility of re-infection in the future. In this context, biodegradable ring annuloplasty of tricuspid valve could be included in non-prosthetic repair techniques, since after a few months not only would it be degraded, but also the subsequent development of a permanent network of fibrous connective tissue will have restored the normal valve function. Unfortunately, our experience with biodegradable ring annuloplasty or matrix scaffolds such as CorMatrix© is poor. On the contrary, others have noted both preliminary and mid-term successful results using biogradable materials [3] even though, their high cost is not to be dismissed, in the current era of stringent budget. On the other hand, in our and most of the surgeons' opinion, autologous pericardium represents the primary option in the repair of any endocardial defect (congenital/acquired heart disease). Major advantages include its low cost, easy-to-use, perfect incorporation within native structures, uncommon colonization by bacteria, rapid endothelization and high endurance even against high pressures of systemic circulation (left ventricle, aorta, etc.) [4]. Besides, patches of fresh autologous pericardium have been used with excellent short- and long-term results, in repairing mitral regurgitation due to annular dilatation, following posterior mitral annuloplasty [5]. Most importantly, the same material appears to be fundamental in the repair of tricuspid valve disease, particularly among patients with a high risk of long-term prosthetic valve endocarditis [6].

  • Open Access

    Right-sided infective endocarditis: surgical management

    by Karolina Akinosoglou, Efstratios Apostolakis, Nikolaos Koutsogiannis, Vassilios Leivaditis, Charalambos A. Gogos

    Right-sided infective endocarditis (RSIE) accounts for 5–10% of all cases of infective endocarditis and is predominantly encountered among injecting drug users (IDUs). RSIE diagnosis requires a high index of suspicion as respiratory symptoms predominate. Prognosis of isolated RSIE is favourable, and most cases (70–80%) resolve following antibiotic administration. Surgical intervention is indicated in patients with persistent infection that does not respond to antibiotic therapy, recurrent pulmonary emboli, intractable heart failure and if the size of a vegetation increases or persists at >1 cm. Techniques can be divided into ‘prosthetic’ (valve replacement or prosthetic annular implantation) or ‘non-prosthetic’ ones (Kay's or De Vega's annuloplasty, bicuspidalization or valvectomy). In IDUs who run a high risk of complications, vegetectomy and valve repair, avoiding artificial material should be considered as the first line of surgical management as is associated with better late survival.


  • Malaria: a haematological disease

    by Karolina S. Akinosoglou, Elena E. Solomou, Charalambos A. Gogos

    Plasmodium falciparum malaria remains a major cause of mortality throughout the tropical world. Haematological abnormalities are considered a hallmark of malaria, bearing an impact on final outcome and representing indices of prognostic and follow-up value. These include severe anaemia, coagulation disturbances, leukocyte numerical or functional changes and spleen involvement. Anaemia involves red blood cell lysis due to parasite invasion, as well as mechanisms of intravascular haemolysis and decreased erythropoiesis. Exchange or blood transfusion is mainly recommended in the management of these patients. Haemorrhagic complications in severe malaria are relatively rare despite prominent thrombocytopenia and dysfunction in the coagulation pathway. Numerical, as well as functional changes in the white blood cell are less dramatic than other blood cell series, but still, remain a significant index of disease progression and ultimate prognosis. Finally, the role of the spleen in severe malaria is multifactorial. Care and vigilance should be taken against splenic rupture which is fatal and can occur despite appropriate antimalarial prophylaxis and treatment.


  • Open Access

    Is the use of at least one internal thoracic artery (ITA) directly associated with increased long-term cardiac-specific survival?☆

    by Efstratios Apostolakis, Karolina Akinosoglou

    Even though, the study by Mohammadi et al. [1] comes up with significant conclusions as to the use of at least one ITA (only as far as the late outcome is considered), it seems to be lacking the liability of a perspective randomized study.


  • Traumatic Chylothorax Following Blunt Thoracic Trauma: Two Conservatively Treated Cases

    by Efstratios Apostolakis, Karolina Akinosoglou, Efstratios Koletsis, Dimitrios Dougenis

    Chylothorax is rare following blunt thoracic trauma; its diagnosis is usually delayed until the puncture or drainage of posttraumatic pleural effusion and its cause is not clear. Mostly, it is attributed to injury or overstretching of major thoracic duct by fractures or other injury of neighboring thoracic spine. We describe of two cases, one unilateral and one bilateral, of chylothorax, both after blunt thoracic trauma. In the first case, there were associated fractures of lower thoracic vertebrae, whereas in the other there was no obvious cause, except striking osteophytic degeneration alongside the thoracic spine. Both cases were successfully treated after 16 and 23 days, respectively, with drainage, starvation, reexpansion of the lung(-s), and total parenteral nutrition. We believe that with the "triad of RST" ("reexpansion, starvation diet, TPN"), conservative treatment will be successful in the majority of cases.